Li, X.;                     Wang, X.;                     Liu, N.;                     Wang, Q.;                     Hu, J.    
        Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System. Molecules 2022, 27, 2082.
    https://doi.org/10.3390/molecules27072082
    AMA Style
    
                                Li X,                                 Wang X,                                 Liu N,                                 Wang Q,                                 Hu J.        
                Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System. Molecules. 2022; 27(7):2082.
        https://doi.org/10.3390/molecules27072082
    
    Chicago/Turabian Style
    
                                Li, Xunan,                                 Xiang Wang,                                 Nian Liu,                                 Qiuyu Wang,                                 and Jing Hu.        
                2022. "Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System" Molecules 27, no. 7: 2082.
        https://doi.org/10.3390/molecules27072082
    
    APA Style
    
                                Li, X.,                                 Wang, X.,                                 Liu, N.,                                 Wang, Q.,                                 & Hu, J.        
        
        (2022). Inhibition of Metastatic Hepatocarcinoma by Combined Chemotherapy with Silencing VEGF/VEGFR2 Genes through a GalNAc-Modified Integrated Therapeutic System. Molecules, 27(7), 2082.
        https://doi.org/10.3390/molecules27072082